Missing Y gene linked to male infertility Updated on: October 01,2025 Missing Y gene linked to male infertility Updated on:October 01,2025
Stem cell scientists unlock blueprint for lab-grown kidney cells with preclinical value Updated on: October 01,2025 Stem cell scientists unlock blueprint for lab-grown kidney cells with preclinical value Updated on:October 01,2025
Using new blood biomarkers, researchers find Alzheimer's disease trial eligibility differs among various populations Updated on: October 01,2025 Using new blood biomarkers, researchers find Alzheimer's disease trial eligibility differs among various populations Updated on:October 01,2025
Bursting HIV's bubble: A new workflow to study HIV-1 genome-containing capsids Updated on: October 01,2025 Bursting HIV's bubble: A new workflow to study HIV-1 genome-containing capsids Updated on:October 01,2025
New tool helps identify unreliable research trials Updated on: October 01,2025 New tool helps identify unreliable research trials Updated on:October 01,2025
3D structure of human clusterin sheds light on Alzheimer's risk factor Updated on: October 01,2025 3D structure of human clusterin sheds light on Alzheimer's risk factor Updated on:October 01,2025
Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer Updated on: September 30,2025 Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer Updated on:September 30,2025
Depression remission endures five years after psilocybin trial Updated on: September 30,2025 Depression remission endures five years after psilocybin trial Updated on:September 30,2025
Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial Updated on: September 30,2025 Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Clinical trial Updated on:September 30,2025
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ non-small cell lung cancer Updated on: September 30,2025 Crizotinib fails to improve disease-free survival in resected early-stage ALK+ non-small cell lung cancer Updated on:September 30,2025